915PLong term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604). (23rd October 2018) - Huddart, R A; Cafferty, F; White, J; Shamash, J; Hennig, I M; Cullen, M; Stenning, S